September 2023 in “Journal of Nutrition and Metabolism” This study found that the ashwagandha extracts ASH-Ext1 and ASH-Ext2 show different pharmacological activities in cell models due to their distinct withanolide proportions, highlighting the need for standardized extraction protocols to ensure consistent therapeutic efficacy.
July 2025 in “SKIN The Journal of Cutaneous Medicine” This review examined the dermatological potential of Withania somnifera (Ashwagandha) and found preliminary evidence of its beneficial effects on various non-malignant skin conditions, such as pigmentary disorders, inflammatory skin issues, wound healing, and scalp health, though further research is needed to confirm these findings.
May 2025 in “Antioxidants” This review highlights how natural products with antioxidant properties can modulate the Wnt signaling pathway, potentially influencing various pathological conditions such as cancer, stroke, and regenerative medicine. It also addresses controversies in the compounds' mechanisms across different models and suggests research directions for future studies.